期刊文献+

线粒体在心肌保护中作用的研究进展

Research progress on the role of mitochondria in myocardial protection
下载PDF
导出
摘要 线粒体是细胞内重要的细胞器,三羧酸循环、电子传递和氧化磷酸化均在线粒体中进行,是细胞中心代谢途径的核心。在生理情况下,其是细胞的能量加工器,维持细胞的正常能量代谢和存活;在缺血再灌注情况下线粒体功能发生紊乱,转而促进细胞的坏死和凋亡。对心肌损伤机制的研究表明,线粒体的功能损害是导致缺血再灌注心肌不可逆损伤的重要原因之一。所以,线粒体保护成为解决心肌损伤的重要途径之一。大量研究表明,线粒体ATP敏感性钾通道、线粒体通透性转换孔、线粒体型硫氧还蛋白、线粒体钙激活钾通道、缝隙连接蛋白43在线粒体的心肌保护中发挥着重要作用。本文就近年来线粒体在心肌保护中的作用研究进展做一综述。 Mitochondria is important intracellular organelle, Krebs cycle, electron transport and oxidative phosphorylation are carried out in mitochondria, which is the center of metabolic pathways. In physiological conditions, mitochondria is the cell′s energy processing device, maintaining the energy metabolism and survival of normal cell; In the case of ischemia reperfusion, mitoehondrial functions are disorder and promote cell necrosis and apoptosis. Studies on the mechanism of myocardial injury suggest that mitochondrial dysfunction is one of the important reasons leading to irreversible myocardial ischemia reperfusion injury. There fore, the protection of mitochondria has become an important way to solve myocardial injury. Numerous studies show that mitochondrial ATP - sensitive potassium channels, mitochondrial permeability transition pore, mitochondrial thioredoxin, mitoehondrial cal- cium - activated potassium channels and connexin 43 play an important role in mitochondrial cardioprotection. The review focuses on the research progress of the role of mitochondria in myocardial protection.
作者 高建波
出处 《天津药学》 2014年第1期46-49,共4页 Tianjin Pharmacy
关键词 线粒体 心肌保护 通道 蛋白质 mitochondria, myocardial protection, channels, protein
  • 相关文献

参考文献3

二级参考文献20

  • 1王震虹,王祥瑞.低氧预处理诱导促红细胞生成素对脑缺血后损伤及认知功能的保护作用[J].中国中西医结合急救杂志,2008,15(6):365-369. 被引量:7
  • 2张颖,郑燕倩,王红卫,杨智昉,刘远谋,李慈珍.新生大鼠心肌细胞培养及电生理特性观察[J].上海交通大学学报(医学版),2007,27(4):398-400. 被引量:5
  • 3Lipsic E,Westenbrink BD,van der Meet P,et al.Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit.Eur J Heart Fail,2008,10:22-29.
  • 4Rafiee P,Shi Y,Su J,et al.Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways.Basic Res Cardiol,2005,100:187-197.
  • 5Shi Y,Rafiee P,Su J,et al.Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels.Basic Res Cardiol,2004,99:173-182.
  • 6Lipsic E,van der Meer P,Henning RH,et al.Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion.J Cardiovasc Pharmacol,2004,44:473-479.
  • 7Huang CH,Hsu CY,Chen HW,et al.Erythropoietin improves the postresuscitation myocardial dysfunction and survival in the asphyxia-induced cardiac arrest model.Shock,2007,28:53-58.
  • 8Huang CH,Hsu CY,Tsai MS,et al.Cardioprotective effects of erythropoietin on postresuscitation myocardial dysfunction in appropriate therapeutic windows.Critical Care Medicine,2008,36:S467-S473.
  • 9Hsu CY,Huang CH,Chang WT,et al.Cardioprotective effect of therapeutic hypothermia for postresuscitation myocardial dysfunction.Shock,2009,32:210-216.
  • 10Singh D,Kolarova JD,Wang S,et al.Myocardial protection by erythropoietin during resuscitation from ventricular fibrillation.Am J Ther,2007,14:361-368.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部